Resveratrol Improves Adipose Insulin Signaling and Reduces the Inflammatory Response in Adipose Tissue of Rhesus Monkeys on High-fat, High-sugar Diet
Overview
Endocrinology
Authors
Affiliations
Obesity is associated with a chronic, low-grade, systemic inflammation that may contribute to the development of insulin resistance and type 2 diabetes. Resveratrol, a natural compound with anti-inflammatory properties, is shown to improve glucose tolerance and insulin sensitivity in obese mice and humans. Here, we tested the effect of a 2-year resveratrol administration on proinflammatory profile and insulin resistance caused by a high-fat, high-sugar (HFS) diet in white adipose tissue (WAT) from rhesus monkeys. Resveratrol supplementation (80 and 480 mg/day for the first and second year, respectively) decreased adipocyte size, increased sirtuin 1 expression, decreased NF-κB activation, and improved insulin sensitivity in visceral, but not subcutaneous, WAT from HFS-fed animals. These effects were reproduced in 3T3-L1 adipocytes cultured in media supplemented with serum from monkeys fed HFS ± resveratrol diets. In conclusion, chronic administration of resveratrol exerts beneficial metabolic and inflammatory adaptations in visceral WAT from diet-induced obese monkeys.
Effects of Resveratrol on Adipocytes: Evidence from In Vitro and In Vivo Studies.
Terzo M, Iantomasi M, Tsiani E Molecules. 2024; 29(22).
PMID: 39598748 PMC: 11596734. DOI: 10.3390/molecules29225359.
Hu Y, Zeng X, Luo Y, Pei X, Zhou D, Zhu B Food Sci Nutr. 2024; 12(9):6398-6410.
PMID: 39554331 PMC: 11561848. DOI: 10.1002/fsn3.4273.
Li J, Zhao J, Tian C, Dong L, Kang Z, Wang J Nutr Metab (Lond). 2024; 21(1):49.
PMID: 39026248 PMC: 11256480. DOI: 10.1186/s12986-024-00829-5.
Extended lifespan in female Drosophila melanogaster through late-life calorie restriction.
Li M, Macro J, Huggins B, Meadows K, Mishra D, Martin D Geroscience. 2024; 46(5):4017-4035.
PMID: 38954128 PMC: 11335708. DOI: 10.1007/s11357-024-01233-w.
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy.
El Oirdi M Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931359 PMC: 11206774. DOI: 10.3390/ph17060692.